Improving breast cancer hormone receptor testing in Tanzania
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
This study looks at how to make breast cancer hormone testing better in Tanzania by talking to survivors, advocates, and healthcare workers to find out what challenges they face.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 85 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Trial ID | NCT05438511 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify challenges in breast cancer diagnosis in Tanzania and explore support mechanisms to enhance the testing process. It involves focus groups and assessments of organizational readiness for implementing changes in breast cancer care. Participants include breast cancer survivors, patient advocates, and healthcare personnel with significant experience in the field. The study seeks to gather insights that could lead to improved testing protocols and patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are breast cancer survivors, patient advocates, and healthcare personnel involved in breast cancer care in Tanzania.
Not a fit: Patients who are not residents of Tanzania or do not have a breast cancer diagnosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to enhanced accuracy and accessibility of breast cancer hormone receptor testing in Tanzania, ultimately improving patient care.
How similar studies have performed: While this study addresses a specific regional challenge, similar approaches in improving cancer care have shown promise in other settings, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2): * Breast cancer survivor, patient advocate or key healthcare personnel * Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with: * \>12 months of employment at the affiliated institution * Administrative or clinical involvement in the delivery of breast cancer care services. * Age 18 years and above * Permanent residents or citizens of Tanzania * Participant and/or LAR willing and able to consent * Fluent in Swahili and/or English by self-report Participant Exclusion Criteria: * Key stakeholder not residing at their particular institutions during data collection will be excluded. Eligibility criteria for Chart Reviews (Aim 1) Inclusion Criteria for chart review: * Age 18 years and above * Permanent residents or citizens of Tanzania * Received breast cancer diagnosis Exclusion Criteria for chart review: * Participants less than 18 years of age
Where this trial is running
New York, New York and 1 other locations
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York, United States (Recruiting)
- Muhimbili University of Health and Allied Sciences — Dar es Salaam, Tanzania (Recruiting)
Study contacts
- Principal investigator: Diana Ng, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Diana Ng, MD
- Email: NgD2@mskcc.org
- Phone: 212-639-7209
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.